NRC · CIK 0000070487 · operating
National Research Corporation operates as a healthcare analytics and insights provider, delivering subscription-based solutions designed to measure and improve patient and employee experience for healthcare organizations. The company's core offerings span patient experience measurement, employee engagement tracking, care transition management, reputation monitoring, and brand loyalty assessment. Its digital platform enables healthcare systems to capture feedback across multiple touchpoints in the patient journey while providing actionable intelligence for service improvement and organizational decision-making. The company also offers Huey AI, an artificial intelligence engine for healthcare experience management, alongside governance solutions tailored for not-for-profit health system boards and physician leadership.
The company's revenue streams include experience solutions addressing patient and employee satisfaction, marketing experience tools for brand assessment and competitive positioning, reputation management services that help healthcare organizations influence consumer perception, and governance advisory services. These solutions serve healthcare organizations seeking to measure operational performance through constituent feedback and translate those insights into strategic improvements.
Headquartered in Lincoln, Nebraska, National Research Corporation was founded in 1981 and maintains a market capitalization of approximately $0.3 billion. The company operates as a publicly traded entity on Nasdaq, serving a broad customer base across the United States healthcare sector through its subscription-based service model.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $1.04 | $1.05 | -16.8% | |
| 2023 | $1.25 | $1.26 | -1.6% | |
| 2022 | $1.27 | $1.28 | -13.0% | |
| 2021 | $1.46 | $1.47 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | $2.17 | $2.22 | +28.4% | |
| 2011 | $1.69 | $1.73 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-17 | 0001437749-25-007867 | SEC ↗ |
| 2023-12-31 | 2024-02-27 | 0001437749-24-005690 | SEC ↗ |
| 2022-12-31 | 2023-03-03 | 0001437749-23-005305 | SEC ↗ |
| 2021-12-31 | 2022-03-04 | 0001437749-22-005273 | SEC ↗ |
| 2020-12-31 | 2021-03-05 | 0001437749-21-005096 | SEC ↗ |
| 2019-12-31 | 2020-03-06 | 0001437749-20-004493 | SEC ↗ |
| 2018-12-31 | 2019-03-08 | 0001437749-19-004393 | SEC ↗ |
| 2017-12-31 | 2018-03-14 | 0001437749-18-004585 | SEC ↗ |
| 2016-12-31 | 2017-03-03 | 0001437749-17-003759 | SEC ↗ |
| 2015-12-31 | 2016-03-04 | 0001437749-16-026817 | SEC ↗ |
| 2014-12-31 | 2015-03-04 | 0001437749-15-004044 | SEC ↗ |
| 2013-12-31 | 2014-03-04 | 0001437749-14-003333 | SEC ↗ |
| 2012-12-31 | 2013-03-01 | 0001437749-13-002206 | SEC ↗ |
| 2011-12-31 | 2012-03-01 | 0001437749-12-001932 | SEC ↗ |
| 2010-12-31 | 2011-03-25 | 0001437749-11-001745 | SEC ↗ |
| 2009-12-31 | 2010-03-31 | 0001144204-10-017127 | SEC ↗ |
| 2008-12-31 | 2009-03-31 | 0001362310-09-004617 | SEC ↗ |
| 2007-12-31 | 2008-03-28 | 0000897069-08-000690 | SEC ↗ |